Cargando…
CU06-1004 (endothelial dysfunction blocker) ameliorates astrocyte end-feet swelling by stabilizing endothelial cell junctions in cerebral ischemia/reperfusion injury
ABSTRACT: Cerebral ischemia, or stroke, is widespread leading cause of death and disability. Surgical and pharmacological interventions that recover blood flow are the most effective treatment strategies for stroke patients. However, restoring the blood supply is accompanied by severe reperfusion in...
Autores principales: | Kim, Dong Young, Zhang, Haiying, Park, Songyi, Kim, Yeaji, Bae, Cho-Rong, Kim, Young-Myeong, Kwon, Young-Guen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297708/ https://www.ncbi.nlm.nih.gov/pubmed/32415357 http://dx.doi.org/10.1007/s00109-020-01920-z |
Ejemplares similares
-
CU06-1004 Alleviates Experimental Colitis by Modulating Colonic Vessel Dysfunction
por: Kim, Ye-Seul, et al.
Publicado: (2020) -
Efficacy of CU06-1004 via regulation of inflammation and endothelial permeability in LPS-induced acute lung injury
por: Kim, Yeomyeong, et al.
Publicado: (2023) -
The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice
por: Bae, Cho-Rong, et al.
Publicado: (2020) -
Correction: The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice
por: Bae, Cho-Rong, et al.
Publicado: (2021) -
Long-term administration of CU06-1004 ameliorates cerebrovascular aging and BBB injury in aging mouse model
por: Kim, Hyejeong, et al.
Publicado: (2023)